Products Category
Contact Us
Tel: 0519-85788828
Fax: 0519-89960117
Mobile: 13775037613
E-mail: sales@chemrenpharm.com
Add: 169 Qingliang Road, Changzhou, Jiangsu,China
QQ:
2500035664
Details: |
Description of:SNX5422
PF-04929113 (SNX-5422) is a synthetic prodrug targeting the human heat-shock protein 90 (Hsp90) with potential antineoplastic activity. Although the mechanism of action remains to be fully elucidated, PF-04929113 (SNX-5422) is rapidly converted to SNX-2112, which accumulates in tumors relative to normal tissues. Inhibition of Hsp90 by SNX-2112 may result in the proteasomal degradation of oncogenic client proteins, including HER2/ERBB2, and the inhibition of tumor cell proliferation. Theoretical analysis:SNX5422 M.Wt: 521.53 Formula: C25H30F3N5O4 Solubility: Unknown Purity: >99% Storage: at -20℃ 2 years CAS No: 908115-27-5 Availability and price:SNX5422 Pakage:25mg/50mg/100mg/250mg/500mg/1g/5g Stock : in stock We offer significant discount for larger quantity order. For quotation, question, and order, please send email to : sales@chemrenpharm.com Quality control data: Quality Control by H-NMR,C-NMR,LC-MS,HPLC. Product will be shipped with supporting analytical data. Fast delivery about 4-5 working days |
Related Products : |
|
|
|
|
||||||||
|
|
|